Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy | BMC Cancer | Full
PPT - Overall Survival and Progression-Free Survival PowerPoint Presentation - ID:4064400
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials - European Journal of Cancer
Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450) - Journal of Thoracic Oncology
Cancers | Free Full-Text | Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma
Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined - Annals of Oncology
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Relationship between Overall Survival and Response or Progression-Free Survival in Advanced Non–Small Cell Lung Cancer Patients Treated with Anti–PD-1/PD-L1 Antibodies - Journal of Thoracic Oncology
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy | British Journal of Cancer
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Kaplan-Meier survival curves of progression-free survival and overall... | Download Scientific Diagram
Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
Progression-free survival and overall survival in all patients. | Download Scientific Diagram
Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials - ScienceDirect
Correlation between treatment effects on response rate and progression-free survival and overall survival in trials of targeted therapies in molecularly enriched populations - ESMO Open
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer | NEJM
Predicting Overall Survival and Progression-Free Survival Using Tumor Dynamics in Advanced Breast Cancer Patients | Semantic Scholar
Predictors of Response, Progression-Free Survival, and Overall Survival in Patients With Lung Cancer Treated With Immune Checkpoint Inhibitors - Journal of Thoracic Oncology
Progression-free survival and overall survival. Progression-free... | Download Scientific Diagram
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG
